Pavasini, R.; Fabbri, G.; Marchini, F.; Bianchi, N.; Deserio, M.A.; Sanguettoli, F.; Verardi, F.M.; Segala, D.; Pompei, G.; Tonet, E.;
et al. Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome. J. Clin. Med. 2022, 11, 554.
https://doi.org/10.3390/jcm11030554
AMA Style
Pavasini R, Fabbri G, Marchini F, Bianchi N, Deserio MA, Sanguettoli F, Verardi FM, Segala D, Pompei G, Tonet E,
et al. Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome. Journal of Clinical Medicine. 2022; 11(3):554.
https://doi.org/10.3390/jcm11030554
Chicago/Turabian Style
Pavasini, Rita, Gioele Fabbri, Federico Marchini, Nicola Bianchi, Maria Angela Deserio, Federico Sanguettoli, Filippo Maria Verardi, Daniela Segala, Graziella Pompei, Elisabetta Tonet,
and et al. 2022. "Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome" Journal of Clinical Medicine 11, no. 3: 554.
https://doi.org/10.3390/jcm11030554
APA Style
Pavasini, R., Fabbri, G., Marchini, F., Bianchi, N., Deserio, M. A., Sanguettoli, F., Verardi, F. M., Segala, D., Pompei, G., Tonet, E., Serenelli, M., Caglioni, S., Guardigli, G., Campo, G., & Cultrera, R.
(2022). Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome. Journal of Clinical Medicine, 11(3), 554.
https://doi.org/10.3390/jcm11030554
